Showing results (501-510 of 1,104) with videos related to

Sort By:
Pageof 111
International Journal of Cancer|June 15, 2011
An American founder mutation in MLH1Jerneja Tomsic, Sandya Liyanarachchi, Heather Hampel, et al.
Public Health|November 19, 2011
Thinking outside the box: Aboriginal people's suggestions for conducting health studies with Aboriginal communitiesM A Maar, N E Lightfoot, M E Sutherland, et al.
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitorM Raymond V Finlay, David Buttar, Susan E Critchlow, et al.
Molecular Ecology|March 7, 2000
Disparate phylogeographic patterns of molecular genetic variation in four closely related South American small cat speciesW E Johnson, J P Slattery, E Eizirik, et al.
Neurogenetics|March 7, 2008
Is the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?M Y Frédéric, F Clot, L Cif, et al.
Clinical Lung Cancer|November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung CancerRay D Page, Leylah M Drusbosky, Hiba Dada, et al.
JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Inherited Metabolic Disease|June 18, 2022
ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelinesDaniah Albokhari, Bobby G Ng, Alis Guberinic, et al.
Clinical Breast Cancer|July 25, 2008
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research GroupJohn T Hamm, John W Wilson, Priya Rastogi, et al.
Pageof 111